Zheng C - Search Results

1

PDCD4 interacting with PIK3CB and CTSZ promotes the apoptosis of multiple myeloma cells.

Liu L, Feng X, Fan C, Kong D, Feng X, Sun C, Xu Y, Li B, Jiang Y, Zheng C. Liu L, et al. Among authors: zheng c. FASEB J. 2024 Aug;38(16):e70024. doi: 10.1096/fj.202400687R. FASEB J. 2024. PMID: 39190024

2

PD1 blockade enhances cytotoxicity of in vitro expanded natural killer cells towards myeloma cells.

Guo Y, Feng X, Jiang Y, Shi X, Xing X, Liu X, Li N, Fadeel B, Zheng C. Guo Y, et al. Among authors: zheng c. Oncotarget. 2016 Jul 26;7(30):48360-48374. doi: 10.18632/oncotarget.10235. Oncotarget. 2016. PMID: 27356741 Free PMC article.

3

Telomere length is positively associated with the expression of IL‑6 and MIP‑1α in bone marrow mesenchymal stem cells of multiple myeloma.

Li S, Jiang Y, Li A, Liu X, Xing X, Guo Y, Xu Y, Hao Y, Zheng C. Li S, et al. Among authors: zheng c. Mol Med Rep. 2017 Sep;16(3):2497-2504. doi: 10.3892/mmr.2017.6885. Epub 2017 Jun 29. Mol Med Rep. 2017. PMID: 28677723 Free PMC article.

4

Serum Interleukin-9 Concentration Is Associated with the Hemoglobin Level and Renal Function in Patients with Multiple Myeloma.

Chang Y, Xing X, Jiang Y, Shi X, Xu Y, Li A, Feng X, Zhang Y, Kong D, Zheng C. Chang Y, et al. Among authors: zheng c. Ann Clin Lab Sci. 2019 Sep;49(4):513-518. Ann Clin Lab Sci. 2019. PMID: 31471342

5

Disulfiram/copper markedly induced myeloma cell apoptosis through activation of JNK and intrinsic and extrinsic apoptosis pathways.

Xu Y, Zhou Q, Feng X, Dai Y, Jiang Y, Jiang W, Liu X, Xing X, Wang Y, Ni Y, Zheng C. Xu Y, et al. Among authors: zheng c. Biomed Pharmacother. 2020 Jun;126:110048. doi: 10.1016/j.biopha.2020.110048. Epub 2020 Mar 4. Biomed Pharmacother. 2020. PMID: 32145587 Free article.

6

Novel Small Molecular Compound AE-848 Potently Induces Human Multiple Myeloma Cell Apoptosis by Modulating the NF-κB and PI3K/Akt/mTOR Signaling Pathways.

Xu Y, Feng X, Zhou Q, Jiang W, Dai Y, Jiang Y, Liu X, Li S, Wang Y, Wang F, Li A, Zheng C. Xu Y, et al. Among authors: zheng c. Onco Targets Ther. 2020 Dec 22;13:13063-13075. doi: 10.2147/OTT.S270090. eCollection 2020. Onco Targets Ther. 2020. PMID: 33376355 Free PMC article.

7

Therapeutic effect and mechanism of ibrutinib combined with dexamethasone on multiple myeloma.

Li S, Sun L, Zhou Q, Li S, Liu X, Xiao J, Xu Y, Wang F, Jiang Y, Zheng C. Li S, et al. Among authors: zheng c. Pharmazie. 2021 Feb 25;76(2):92-96. doi: 10.1691/ph.2021.0917. Pharmazie. 2021. PMID: 33714285

8

PDCD4 Negatively Regulated Osteogenic Differentiation and Bone Defect Repair of Mesenchymal Stem Cells Through GSK-3β/β-Catenin Pathway.

Jiang Y, Li S, Zhou Q, Liu S, Liu X, Xiao J, Jiang W, Xu Y, Kong D, Wang F, Wei F, Zheng C. Jiang Y, et al. Among authors: zheng c. Stem Cells Dev. 2021 Aug 15;30(16):806-815. doi: 10.1089/scd.2021.0041. Epub 2021 Jul 2. Stem Cells Dev. 2021. PMID: 34088227

9

Tim-3 Blockade Elicits Potent Anti-Multiple Myeloma Immunity of Natural Killer Cells.

Jiang W, Li F, Jiang Y, Li S, Liu X, Xu Y, Li B, Feng X, Zheng C. Jiang W, et al. Among authors: zheng c. Front Oncol. 2022 Feb 25;12:739976. doi: 10.3389/fonc.2022.739976. eCollection 2022. Front Oncol. 2022. PMID: 35280800 Free PMC article.

10

Lactate dehydrogenase A is implicated in the pathogenesis of B-cell lymphoma through regulation of the FER signaling pathway.

Feng X, Ren J, Zhang X, Kong D, Yin L, Zhou Q, Wang S, Li A, Guo Y, Wang Y, Feng X, Wang X, Niu J, Jiang Y, Zheng C. Feng X, et al. Among authors: zheng c. Biofactors. 2024 Sep-Oct;50(5):1024-1038. doi: 10.1002/biof.2053. Epub 2024 Mar 22. Biofactors. 2024. PMID: 38516823

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,171 results

Search Page

Filters